Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis

被引：0
|
作者：
Radwa El Borolossy
Lamia Mohamed El Wakeel
Ihab El Hakim
Nagwa Sabri
机构：
[1] Ain Shams University,Department of Clinical Pharmacy, Faculty of Pharmacy
[2] Ain Shams University,Department of Pediatrics, Faculty of Medicine
来源：
Pediatric Nephrology | 2016年 / 31卷
关键词：
Pediatric patients; Hemodialysis; Nicotinamide; Hyperphosphatemia; Lipid profile;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：289 / 296
页数：7
相关论文
共 50 条
  • [1] Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis
    El Borolossy, Radwa
    El Wakeel, Lamia Mohamed
    El Hakim, Ihab
    Sabri, Nagwa
    PEDIATRIC NEPHROLOGY, 2016, 31 (02) : 289 - 296
  • [2] EFFICACY AND SAFETY OF MODIFIED RELEASE NICOTINAMIDE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN HEMODIALYSIS PATIENTS
    Ketteler, Markus
    Zidek, Walter
    Karus, Michael
    Hellmann, Burkhard
    Ammer, Richard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 267 - 267
  • [3] Nicotinamide suppresses hyperphosphatemia in hemodialysis patients
    Takahashi, Y
    Tanaka, A
    Nakamura, T
    Fukuwatari, T
    Shibata, K
    Shimada, N
    Ebihara, I
    Koide, H
    KIDNEY INTERNATIONAL, 2004, 65 (03) : 1099 - 1104
  • [4] Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
    Zeng, Qian
    Zhong, Yuanlong
    Yu, Xiqiu
    RENAL FAILURE, 2023, 45 (01)
  • [5] Safety and efficacy of FosrenolTM in the long-term treatment of hyperphosphatemia in hemodialysis patients
    Finn, WF
    Joy, MS
    9TH ASIAN PACIFIC CONGRESS OF NEPHROLOGY, 2003, : 199 - 202
  • [6] Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial
    Ketteler, Markus
    Wiecek, Andrzej
    Rosenkranz, Alexander R.
    Pasch, Andreas
    Rekowski, Jan
    Hellmann, Burkhard
    Karus, Michael
    Ammer, Richard
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (03): : 594 - 604
  • [7] The efficacy and safety of niacin on hyperphosphatemia in ESRD patients undergoing hemodialysis: randomized controlled trial
    Ahmed, Hanan Mahmoud
    Yossif, Esraa
    Abd-Elkader, Alaa S.
    Abdel Aziz, Essam M.
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2022, 34 (01):
  • [8] The efficacy and safety of niacin on hyperphosphatemia in ESRD patients undergoing hemodialysis: randomized controlled trial
    Hanan Mahmoud Ahmed
    Esraa Yossif
    Alaa S. Abd-Elkader
    Essam M. Abdel Aziz
    The Egyptian Journal of Internal Medicine, 2022, 34
  • [9] Efficacy and Safety of Tenapanor on Hyperphosphatemia in Japanese Hemodialysis Patients: Results of a Randomized Phase 3 Trial
    Fukagawa, Masafumi
    Ikejiri, Kazuaki
    Kinoshita, Jun
    Nakanishi, Kaoru
    Akizawa, Tadao
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 94 - 94
  • [10] Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial
    Block, Geoffrey A.
    Rosenbaum, David P.
    Yan, Andrew
    Chertow, Glenn M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (04): : 641 - 652
12345